Shanghai, February 21, 2024 – Shanghai Simple Touch Technology has announced that it received NMPA approval for its state-of-the-art CT-guided lung biopsy robot, the RC120 Navigation and Positioning System.
Featuring cutting-edge "CT Imaging and Intelligent Sensing Integration Technology," the RC120 enables medical professionals to efficiently plan the puncture path, precisely target lesions, and significantly mitigate the risks associated with puncture procedures. The system simplifies preoperative procedures by eliminating the need for marking or registration, addressing the challenge of puncture accuracy head-on.
The scope of the RC120 extends well beyond lung biopsies, with wide-ranging applications in minimally invasive interventional medicine. It offers diverse surgical solutions that cater to the growing needs of various medical departments. In addition to puncture capabilities, the RC120 is also compatible with an array of treatments including ablation, particle implantation, and precise drug administration, providing high-quality, accurate, and faster support for complex and precision-demanding minimally invasive surgeries.
About Simple Touch Technology
Shanghai Simple Touch Technology Co., Ltd. is at the forefront of the medical technology industry, focusing on the independent development of high-performance surgical robots. The company's unique core technologies and products assist surgeons in performing operations with greater safety, efficiency, and precision.
For more information, please visit:https://www.simple-touch.cn